Market Overview

Geneious Desktop Software to Be Renamed to Geneious Prime


Biomatters today announces that Geneious, its world-leading desktop
suite of molecular biology and sequence analysis tools, will be renamed
to Geneious Prime later this year.

Geneious began as a way to reduce time spent on managing and analyzing
biological data and is now widely used in biotechnology and academic
research. Over half a million scientists have used Geneious in the 13
years since its first release. In the last two years Geneious has
doubled the size of its customer base in commercial biotech and pharma,
particularly driven by customers working in biologic drug development.

President and CEO Brett Ammundsen commented "Over the last decade our
customers have associated Geneious with trust, expertise and
approachability. As we continue to grow and adapt to the market, that
same Geneious experience has to encompass a wider range of solutions for
customers who have been with us for years, as well as new customers. The
time has come to give our desktop software its own identity."

Director of Marketing, Melissa Pentecost says "Prime connotes being the
best in class and the first choice for researchers and lab managers who
are seeking a solution to their sequence data analysis and data
management challenges. It also references its status as the original
solution that we brought to market."

About Geneious Prime

Geneious Prime increases efficiency and enables better science as the
world's most recognized and comprehensive desktop suite of molecular
biology and NGS analysis tools. First released in 2005, Geneious Prime
is used by over 4,000 universities, institutes and commercial companies
in 125 countries.

View Comments and Join the Discussion!